Nutshell Therapeutics Funding: $75M Raised, Series A (2022)
Nutshell Therapeutics is based in Shanghai, China. It has raised $75M in total funding. Latest round: Series A.
Nutshell Therapeutics funding overview
Nutshell Therapeutics is based in Shanghai, China. Nutshell Therapeutics has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2022. The round record for Nutshell Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Genesis Capital, SAIC Capital China, Kunlun Investment, Kunlun Capital, Source Code Capital, MPCi and 1 others. 7 distinct backers are named across the disclosed rounds.
Frequently asked about Nutshell Therapeutics funding
How much has Nutshell Therapeutics raised?
Nutshell Therapeutics has raised $75M in total disclosed funding across the rounds on record.
Who has invested in Nutshell Therapeutics?
Genesis Capital, SAIC Capital China, Kunlun Investment, Kunlun Capital, Source Code Capital, MPCi are named among the investors backing Nutshell Therapeutics.
What was the latest Nutshell Therapeutics funding round?
The most recent disclosed round is a Series A, announced in March 2022.
Where is Nutshell Therapeutics based?
Nutshell Therapeutics is based in Shanghai, China.
When did Nutshell Therapeutics last raise?
The last disclosed Nutshell Therapeutics round closed in March 2022 at Series A.
Every Nutshell Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Shanghai at a similar stage.
